Your browser doesn't support javascript.
loading
Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem.
Edgar, K; Jackson, D; Rhodes, K; Duffy, T; Burman, C-F; Sharples, L D.
Afiliação
  • Edgar K; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Jackson D; Statistical Innovation, Oncology R&D, AstraZeneca, AstraZeneca, Cambridge, UK.
  • Rhodes K; Statistical Innovation, Oncology R&D, AstraZeneca, AstraZeneca, Cambridge, UK.
  • Duffy T; Statistical Innovation, BioPharmaceutical R&D, AstraZeneca, Gothenburg, Sweden.
  • Burman CF; Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Sharples LD; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Stat Methods Med Res ; 30(7): 1725-1743, 2021 07.
Article em En | MEDLINE | ID: mdl-34077288
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article